Hongmei Q. Li

639 Longmian Avenue
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Discovery of an Indole-Based p53-Y220C Reactivator with In Vivo Antitumor Activity via Structure-Guided Design.

Discovery of an Indole-Based p53-Y220C Reactivator with In Vivo Antitumor Activity via Structure-Guided Design.

Journal: Journal of medicinal chemistry

Published: June 10, 2026

Comment on "Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study".

Comment on "Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: March 11, 2026

Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia.

Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia.

Journal: Journal of medicinal chemistry

Published: October 28, 2025

Preparation, characterization, and antioxidant activity of bovine bone peptide-calcium chelate against oxidative stress-induced injury in Caco-2 cells.

Preparation, characterization, and antioxidant activity of bovine bone peptide-calcium chelate against oxidative stress-induced injury in Caco-2 cells.

Journal: Bioorganic chemistry

Published: July 08, 2025

DrugGPS: Attention-guided multimodal fusion for intelligent exploration of drug-target and drug-disease interactions.

DrugGPS: Attention-guided multimodal fusion for intelligent exploration of drug-target and drug-disease interactions.

Journal: British journal of pharmacology

Published: July 02, 2025

Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate Cancer.

Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: April 15, 2025

Efficacy and Safety of 177Lu-DOTA-IBA in Tumor Bone Metastasis Treatment: A Prospective Clinical Trial.

Efficacy and Safety of 177Lu-DOTA-IBA in Tumor Bone Metastasis Treatment: A Prospective Clinical Trial.

Journal: Clinical nuclear medicine

Published: January 08, 2025

Prioritizing oral bioavailability in drug development strategies.

Prioritizing oral bioavailability in drug development strategies.

Journal: Future medicinal chemistry

Published: December 26, 2024

Discovery of N-Phenyl-5-propyl-1H-pyrazole-3-carboxamide, with Selective Inhibition and Degradation of HDAC6 for the Treatment of Acute Liver Injury.

Discovery of N-Phenyl-5-propyl-1H-pyrazole-3-carboxamide, with Selective Inhibition and Degradation of HDAC6 for the Treatment of Acute Liver Injury.

Journal: Journal of medicinal chemistry

Published: December 16, 2024

Long-term stable acidic electroreduction of CO2 to C2 products at industrial current density using passivated copper.

Long-term stable acidic electroreduction of CO2 to C2 products at industrial current density using passivated copper.

Journal: Nature communications

Published: December 10, 2024

Discovery of novel spirocyclic derivates as potent androgen receptor antagonists.

Discovery of novel spirocyclic derivates as potent androgen receptor antagonists.

Journal: Bioorganic & medicinal chemistry

Published: October 31, 2024

Polymorphospora lycopeni sp. nov., a lycopene-producing actinomycetes isolated from lakeside soil sample of Baiyangdian.

Polymorphospora lycopeni sp. nov., a lycopene-producing actinomycetes isolated from lakeside soil sample of Baiyangdian.

Journal: International journal of systematic and evolutionary microbiology

Published: October 14, 2024

Showing 1-12 of 59

Last Updated: 09/26/2026